Diabetes

Scientists at the University of Cambridge have been developing artificial pancreas technology to help manage diabetes for more than a decade and have now reported "life-changing" results from trials in young children.

Researchers have developed a new nanotherapy to enhance the effectiveness of a type 1 diabetes treatment. The innovation packages immunosuppressive drugs into nanoparticles to reduce the likelihood of a body rejecting newly transplanted islet cells.

A report from the CDC has found children who have recovered from COVID-19 infection are more likely to develop diabetes than those with no history of infection. The researchers call for more study into the association between COVID-19 and diabetes.

Insulin regulates blood glucose levels, and issues often lead to diabetes. But now, scientists at the Salk Institute have identified another molecular pathway that regulates blood glucose, which could open up a brand new avenue for treating diabetes.

Impressive new research has shown how a common diabetes drug can be inactivated by bacterial enzymes produced in the oral and gut microbiome. The researchers speculate this process may explain why the drug is not effective in some diabetic patients.

Regular exercise is generally a good idea at any age, but maintaining an active lifestyle is especially important as we move into older age. A new discovery from scientists in Australia has shed further light on the reasons why.

Scientists at Harvard University have made a breakthrough that implicates a newly discovered hormone in the onset of diabetes, and shown how it can be targeted to reverse the effects of the disease.

New studies are reporting results from a type 1 diabetes human clinical trial testing a device containing stem cells designed to mature into insulin-secreting cells. The experimental implant was found to be safe, well-tolerated and mildly effective.

A new study has drilled into the relationship between the timing of our meals and the body's blood glucose levels, finding that those chowing down after dark may be at greater risk of diabetes and obesity.

Yale researchers have developed a new oral medication for type 1 diabetes. In tests in mice, the drug quickly adjusted insulin levels, restored metabolic functions and reversed inflammation, opening up a potential way to prevent the disease.

A new study has explored how damaged, lingering cells called senescent cells can negatively influence the behavior of fat cells, and demonstrated how their removal can alleviate diabetes symptoms in obese mice.

A study is proposing blood levels of a specific protein may serve as a predictor of type 2 diabetes up to almost two decades before any symptoms appear. The findings indicate a blood test could offer a way to assess future risk of developing the disease.